Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
8
pubmed:dateCreated
2008-7-28
pubmed:abstractText
Universal ganciclovir (GCV) prophylaxis is a strategy aimed at reducing cytomegalovirus (CMV) infection and delaying the development of bronchiolitis obliterans syndrome (BOS). However, the optimal duration of GCV prophylaxis remains unclear. We report our experience with GCV prophylaxis administered indefinitely and its effect on CMV pneumonitis, BOS and survival after lung transplantation (LT).
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
1557-3117
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
27
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
875-81
pubmed:meshHeading
pubmed-meshheading:18656801-Adolescent, pubmed-meshheading:18656801-Adult, pubmed-meshheading:18656801-Aged, pubmed-meshheading:18656801-Antiviral Agents, pubmed-meshheading:18656801-Bronchiolitis Obliterans, pubmed-meshheading:18656801-Cohort Studies, pubmed-meshheading:18656801-Cytomegalovirus Infections, pubmed-meshheading:18656801-Dose-Response Relationship, Drug, pubmed-meshheading:18656801-Female, pubmed-meshheading:18656801-Ganciclovir, pubmed-meshheading:18656801-Humans, pubmed-meshheading:18656801-Immunosuppression, pubmed-meshheading:18656801-Lung Transplantation, pubmed-meshheading:18656801-Male, pubmed-meshheading:18656801-Middle Aged, pubmed-meshheading:18656801-Opportunistic Infections, pubmed-meshheading:18656801-Pneumonia, pubmed-meshheading:18656801-Retrospective Studies, pubmed-meshheading:18656801-Treatment Outcome
pubmed:year
2008
pubmed:articleTitle
Ganciclovir for cytomegalovirus: a call for indefinite prophylaxis in lung transplantation.
pubmed:affiliation
Texas Transplant Center, Department of Internal Medicine, University of Texas Medical Branch, Galveston, Texas 77555-0772, USA. vgvalent@utmb.edu
pubmed:publicationType
Journal Article, Comparative Study